Trials / Completed
CompletedNCT01200550
The Study to Describe Symptom Control and Impact on Daily Life in Gastroesophageal Reflux Disease (GERD) Patients
An Epidemiological, Observational Study to Describe Symptom Control and Impact on Daily Life in Patients With Gastroesophageal Reflux Disease (GERD)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,233 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate symptoms control and impact on daily life from patients perspective using specific GERD Impact Scale(GIS) questionnaire. The another objective is to obtain local epidemiological data for Bosnia and Herzegovina regarding GERD treatment in primary care.
Conditions
Timeline
- Start date
- 2010-09-01
- Primary completion
- 2011-09-01
- Completion
- 2011-11-01
- First posted
- 2010-09-13
- Last updated
- 2012-04-17
Locations
23 sites across 1 country: Bosnia and Herzegovina
Source: ClinicalTrials.gov record NCT01200550. Inclusion in this directory is not an endorsement.